A severe relapse of pemphigus vulgaris after SARS‐CoV ‐2 vaccination
Journal of the European Academy of Dermatology and Venereology · 2023
DOI: 10.1111/jdv.19414 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von L Ligrone und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatologic Unit, Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Salerno, Italy. Hauptthemen laut MEDLINE: Pemphigus, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dermatologic Unit, Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Salerno, Italy.
- Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana' University of Salerno, Salerno, Italy.
- Dermatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
ORCID-Profile: F Cillo, A Raimondo
Zitieren
APA
Ligrone, L., Lembo, S., Cillo, F., Spennato, S., Fabbrocini, G., & Raimondo, A. (2023). A severe relapse of pemphigus vulgaris after SARS‐CoV ‐2 vaccination. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19414
Vancouver
Ligrone L, Lembo S, Cillo F, Spennato S, Fabbrocini G, Raimondo A. A severe relapse of pemphigus vulgaris after SARS‐CoV ‐2 vaccination. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.19414
BibTeX
@article{Ligrone2023,
author = {Ligrone, L and Lembo, S and Cillo, F and Spennato, S and Fabbrocini, G and Raimondo, A},
title = {A severe relapse of pemphigus vulgaris after SARS‐CoV ‐2 vaccination},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2023},
doi = {10.1111/jdv.19414}
}
EUVIMED